SCHEMBL2888975

SCHEMBL2888975

O=C(C=Cc1ccccc1)O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 8/20 0.66
▸ MGLL Q99685 1/20 0.44
▸ MCL1 Q07820 1/20 0.43
▸ CYP2C19 P33261 2/20 0.41
▸ LMNA P02545 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ TNKS O95271 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HCAR2 Q8TDS4 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10423625 1.00 BCHE (0.66) BCHEMGLLMCL1CYP2C19LMNA
SCHEMBL2888973 1.00 BCHE (0.66) BCHEMGLLMCL1CYP2C19LMNA
SCHEMBL26272968 0.93 BCHE (0.73) BCHEMGLLCYP2C19LMNAKMT2A
SCHEMBL19821134 0.93 BCHE (0.73) BCHEMGLLCYP2C19LMNAKMT2A
SCHEMBL26273017 0.93 BCHE (0.73) BCHEMGLLCYP2C19LMNAKMT2A
SCHEMBL12675894 0.93 BCHE (0.58) BCHEMGLLMCL1HDAC2
SCHEMBL12675213 0.93 BCHE (0.58) BCHEMGLLMCL1HDAC2
SCHEMBL12675214 0.93 BCHE (0.58) BCHEMGLLMCL1HDAC2
SCHEMBL17705954 0.88 BCHE (0.63) BCHECYP2C9HDAC3HDAC4HDAC1
SCHEMBL5630321 0.88 BCHE (0.63) BCHECYP2C9HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7794802-B2 Polymerizable liquid crystal compound, composition and polymer CHISSO CORPORATION (JP) 2010-09-14 — — US disclosed
US-20100076171-A1 Polymerizable liquid crystal compound, composition and polymer CHISSO CORPORATION 2010-03-25 — — US disclosed
WO-2007098022-A2 ULTRAVIOLET ABSORBER FOR COSMETICS AND POLYMERIC MATERIALS IOWA CORN PROMOTION BOARD (US) 2007-08-30 — — WO disclosed
US-20070189990-A1 Ultraviolet absorber for cosmetics and polymeric materials UNITED STATES DEPARTMENT OF ENERGY 2007-08-16 — — US disclosed
WO-2004087835-A1 CHIRAL POLYMERIZABLE COMPOUNDS MERCK PATENT GMBH (DE) 2004-10-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070189990-A1 Ultraviolet absorber for cosmetics and polymeric materials ADH1A, SORD, ALDOA BCHE 3602/4885MGLL 546/4885MCL1 3806/4885
US-20100076171-A1 Polymerizable liquid crystal compound, composition and polymer LSS, SFXN1, FRG1 BCHE 4329/4885MGLL 341/4885MCL1 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback